Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group
Clinical trial NCT04230759 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04230759
- Sponsor
- Goethe University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-07
- Primary completion
- 2026-12-31
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.